Shared Resource: Proteomics and Metabolomics
共享资源:蛋白质组学和代谢组学
基本信息
- 批准号:9001914
- 负责人:
- 金额:$ 42.55万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-02-01 至 2019-12-31
- 项目状态:已结题
- 来源:
- 关键词:Animal OrganBiological AssayBiological ModelsCancer BiologyCancer Center Support GrantChromatographyClinicalConsultationsCore FacilityData AnalysesDevelopmentDiagnosticDoctor of PhilosophyFred Hutchinson Cancer Research CenterGoalsHigh Pressure Liquid ChromatographyInformaticsIsotopesJointsLaboratoriesMalignant NeoplasmsMass Spectrum AnalysisMedicineMetabolic PathwayMissionModificationMolecularMolecular WeightNMR SpectroscopyPhospholipidsPost-Translational Protein ProcessingPreparationProteinsProteomicsProteomics Shared ResourceProtocols documentationResearchResearch PersonnelResource SharingResourcesSamplingSerumServicesSiteTestingTracerTrainingUniversitiesValidationWashingtonabstractinganticancer researchaqueousbasebiomarker discoverycost effectiveinstrumentationliquid chromatography mass spectrometrymeetingsmembermetabolomicsmetabolomics resourceoperationphosphoproteomicsprotein complexresearch studytool
项目摘要
Proteomics and Metabolomics Shared Resource
Project Summary/Abstract
The Proteomics and Metabolomics Shared Resource (PMSR) consists of a Fred Hutchinson Cancer Research
Center (FHCRC)-based Proteomics/Metabolomics laboratory and a University of Washington-South Lake
Union (UW-SLU) laboratory. The Proteomics section of the PMSR was formed in November 2002 with the goal
of providing cost-effective high performance liquid chromatography and mass spectrometry-based proteomics
services to Cancer Consortium (Consortium) members. The Proteomics resource's mission is to provide high
quality service in a timely manner for small- and large-scale qualitative and quantitative proteomics analyses,
protein modification characterization, and targeted proteomic analyses. These services have evolved from
small-scale identification of protein complexes in model systems and identifying modifications on highly purified
proteins to large-scale biomarker discovery/validation experiments in serum samples and phosphoproteomics
analysis of animal organs. The PMSR received an outstanding merit assessment in 2008.
In 2010, the PMSR was expanded to include metabolomics research and related resources through the joint
recruitment of Daniel Raftery, Ph.D., a recognized leader in metabolomics research, to FHCRC and the
University of Washington (UW). Along with the proteomics services mentioned above, the resource now
provides untargeted profiling of aqueous metabolites and lipids (lipidomics), targeted profiling of metabolites
from numerous metabolic pathways via mass spectrometry and nuclear magnetic resonance spectroscopy,
and isotope tracer capabilities. The PMSR is also rapidly developing mass spectrometry phospholipid
analysis. The resource is committed to developing and implementing new proteomics and metabolomics tools
in order to uncover the molecular details that influence cancer biology and to support development of
diagnostic and clinical tests.
Scientific operations of the Proteomics and Metabolomics resource are divided between FHCRC and UW-
medicine sites. Dr. Gafken oversees all operations at FHCRC and Dr. Raftery oversees those at UW. Drs.
Gafken and Raftery meet on a monthly to coordinate activities, or more frequently if needed for specific
projects. All proteomics-based projects are performed at FHCRC while metabolomics-based projects are
divided between the two sites. Metabolomics projects for which established, routine assays are available are
performed at FHCRC while those metabolomics projects that are non-routine and require significant
development are performed at UW. As new metabolomics assays are developed and refined at the UW site,
FHCRC-based staff will be trained on these protocols to make them more widely available as a service. All
NMR capabilities and NMR-related projects will be conducted at UW-SLU.
蛋白质组学和代谢组学共享资源
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Philip R Gafken其他文献
Philip R Gafken的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Philip R Gafken', 18)}}的其他基金
Acquisition of OrbiTrap Eclipse w/FAIMS mass spectrometer
收购 OrbiTrap Eclipse 和 FAIMS 质谱仪
- 批准号:
10412531 - 财政年份:2022
- 资助金额:
$ 42.55万 - 项目类别:
相似海外基金
Establishment of a new biological assay using Hydra nematocyst deployment
利用水螅刺丝囊部署建立新的生物测定方法
- 批准号:
520728-2017 - 财政年份:2017
- 资助金额:
$ 42.55万 - 项目类别:
University Undergraduate Student Research Awards
POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER) AFTER RADIOLOGICAL AND NUCLEAR EVENTS.
用于确定放射和核事件后组织特异性吸收电离辐射剂量(生物剂量计)的护理点生物测定。
- 批准号:
10368760 - 财政年份:2017
- 资助金额:
$ 42.55万 - 项目类别:
POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER) AFTER RADIOLOGICAL AND NUCLEAR EVENTS.
用于确定放射和核事件后组织特异性吸收电离辐射剂量(生物剂量计)的护理点生物测定。
- 批准号:
10669539 - 财政年份:2017
- 资助金额:
$ 42.55万 - 项目类别:
POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER) AFTER RADIOLOGICAL AND NUCLEAR EVENTS.
用于确定放射和核事件后组织特异性吸收电离辐射剂量(生物剂量计)的护理点生物测定。
- 批准号:
9570142 - 财政年份:2017
- 资助金额:
$ 42.55万 - 项目类别:
POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER) AFTER RADIOLOGICAL AND NUCLEAR EVENTS.
用于确定放射和核事件后组织特异性吸收电离辐射剂量(生物剂量计)的护理点生物测定。
- 批准号:
9915803 - 财政年份:2017
- 资助金额:
$ 42.55万 - 项目类别:
COVID-19 Supplemental work: POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER).
COVID-19 补充工作:用于确定组织特异性吸收电离辐射剂量的护理点生物测定(生物剂量计)。
- 批准号:
10259999 - 财政年份:2017
- 资助金额:
$ 42.55万 - 项目类别:
Drug discovery based on a new biological assay system using Yeast knock-out strain collection
基于使用酵母敲除菌株收集的新生物测定系统的药物发现
- 批准号:
21580130 - 财政年份:2009
- 资助金额:
$ 42.55万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Machine learning for automatic gene annotation using high-throughput biological assay data
使用高通量生物测定数据进行自动基因注释的机器学习
- 批准号:
300985-2004 - 财政年份:2005
- 资助金额:
$ 42.55万 - 项目类别:
Postdoctoral Fellowships
Machine learning for automatic gene annotation using high-throughput biological assay data
使用高通量生物测定数据进行自动基因注释的机器学习
- 批准号:
300985-2004 - 财政年份:2004
- 资助金额:
$ 42.55万 - 项目类别:
Postdoctoral Fellowships